Saturday 17 October 2026
Export VTRS’s income statement to Excel — free account
Viatris Inc.
VTRS Healthcare Drug Manufacturers Specialty & Generic
Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.
18.66
0.44
+2.41%
Follow VTRS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 227.80 | 6.66 | 0.00 | 0.00 | 670.00 | 40.29 | 32.91 | 42.98 |
Piotroski F-Score |
4 | 4 | 8 | 7 | 4 | 3 | 5 | 6 | 5 | 3 |
P/S ratio |
1.02 | 1.01 | 0.89 | 0.85 | 0.91 | 0.94 | 0.90 | 1.23 | 1.94 | 1.81 |
Altman Z-Score |
0.61 | 0.97 | 0.93 | 0.95 | 0.73 | 0.52 | 1.08 | 1.17 | 1.32 | 1.17 |
Altman Z″-Score (non-manufacturers) |
0.65 | 1.72 | 1.93 | 1.83 | 0.96 | 1.13 | 1.68 | 1.76 | 1.56 | 1.56 |
P/FCF ratio |
7.52 | 3.33 | 4.88 | 5.37 | 6.48 | 20.38 | 7.27 | 11.99 | 18.36 | 15.47 |
Beneish M-Score |
(3.29) | (2.88) | (2.86) | (2.74) | (2.77) | (2.08) | (2.71) | (2.87) | (2.52) | (2.52) |
P/Operating CF |
17.87 | 30.78 | 24.05 | 72.98 | 31.27 | 311.23 | 15.09 | 22.16 | 46.50 | 57.41 |
Dividend Safety Score |
37 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.99 | 0.80 | 0.67 | 0.65 | 0.80 | 0.49 | 0.87 | 1.16 | 1.73 | 1.80 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.93 | 2.04 | 2.00 | 1.96 | 2.17 | 3.24 | 2.05 | 2.41 | 3.25 | 3.25 |
EV/EBITDA |
9.01 | 9.34 | 7.54 | 6.85 | 8.66 | 19.32 | 8.62 | 9.14 | 11.94 | 16.18 |
EV/Operating CF |
11.95 | 13.07 | 10.62 | 10.61 | 12.84 | 31.45 | 13.07 | 11.77 | 18.75 | 17.57 |
EV/FCF |
14.27 | 6.74 | 10.99 | 12.38 | 15.34 | 70.10 | 16.53 | 23.46 | 30.83 | 27.74 |
Quick Ratio |
0.61 | 0.68 | 0.60 | 0.75 | 0.50 | 0.54 | 0.63 | 0.71 | 0.61 | 0.86 |
Current Ratio |
1.38 | 1.65 | 1.67 | 1.58 | 1.10 | 1.22 | 1.21 | 1.39 | 1.13 | 1.49 |
Net Debt/EBITDA |
4.92 | 4.73 | 4.19 | 3.88 | 5.01 | 13.70 | 4.83 | 4.47 | 4.83 | 7.15 |
Debt/Assets |
44.17% | 38.52% | 38.02% | 38.53% | 42.10% | 46.01% | 43.78% | 42.35% | 44.56% | 48.66% |
Debt/Equity |
1.12 | 0.86 | 0.89 | 0.91 | 1.13 | 1.23 | 1.15 | 1.14 | 1.20 | 1.52 |
Asset Turnover |
0.36 | 0.33 | 0.32 | 0.31 | 0.31 | 0.26 | 0.36 | 0.33 | 0.34 | 0.39 |
Operating CF/Net income |
(0.66) | (3.63) | 53.02 | 1.44 | (2.38) | (1.84) | 107.36 | 6.64 | 2.97 | 4.27 |
Capex/Depreciation |
(0.07) | 0.67 | (0.03) | (0.14) | (0.11) | (0.31) | (0.19) | (0.55) | (0.45) | (0.49) |
Interest Coverage |
(5.65) | 0.02 | 1.34 | 2.73 | (0.05) | (0.42) | 1.38 | 1.67 | 2.69 | 1.54 |
| (21.08%) | (3.24%) | 0.26% | 10.00% | (5.84%) | (3.85%) | 0.14% | 2.77% | 5.70% | 4.60% | |
| (8.93%) | (1.42%) | 0.11% | 3.96% | (2.18%) | (1.44%) | 0.05% | 1.03% | 1.97% | 1.68% | |
ROIC |
(5.58%) | 0.02% | 1.27% | 2.58% | (0.05%) | (0.26%) | 1.78% | 2.21% | 3.10% | 1.62% |
Return on Tangible Assets |
(66.21%) | (9.90%) | 0.69% | 30.06% | (30.17%) | (11.62%) | 0.50% | 8.92% | 21.98% | 9.99% |
Average Days of Receivables |
77.37 | 79.77 | 87.55 | 85.61 | 87.06 | 148.00 | 97.08 | 91.97 | 110.73 | 109.10 |
Research and Development Expense of Revenue |
6.75% | 5.49% | 5.22% | 4.07% | 3.81% | 4.29% | 5.56% | 6.16% | 6.58% | 7.46% |
Selling, General and Administrative Expense of Revenue |
26.53% | 27.85% | 26.38% | 25.70% | 25.32% | 28.00% | 22.29% | 21.35% | 21.63% | 22.56% |
Intangible Assets out of Total Assets |
0.59 | 0.63 | 0.61 | 0.66 | 0.70 | 0.68 | 0.68 | 0.72 | 0.71 | 0.68 |
Share Based Compensation of Revenue |
1.24% | 0.99% | 1.17% | 0.72% | 0.62% | 0.66% | 0.49% | (0.03%) | 0.63% | 0.80% |
Graham Net Nets |
(0.87) | (0.90) | (1.04) | (1.33) | (1.43) | (2.28) | (1.22) | (1.01) | (0.66) | (0.80) |
Graham Number |
0.00 | 0.00 | 4.38 | 25.86 | 0.00 | 0.00 | 3.94 | 19.02 | 27.09 | 21.06 |
Earnings Yield |
(23.81%) | (4.18%) | 0.44% | 15.03% | (7.76%) | (5.92%) | 0.15% | 2.48% | 3.04% | 2.33% |
Free Cash Flow Yield |
13.30% | 30.06% | 20.51% | 18.63% | 15.44% | 4.91% | 13.75% | 8.34% | 5.45% | 6.46% |
Revenue per Share |
12.21 | 12.35 | 12.85 | 13.42 | 14.80 | 19.87 | 22.30 | 22.22 | 22.28 | 21.59 |
Operating CF per Share |
1.98 | 1.93 | 2.42 | 2.47 | 2.50 | 2.05 | 3.50 | 4.55 | 3.86 | 3.99 |
Capex per Share |
(0.32) | 1.81 | (0.08) | (0.35) | (0.41) | (1.13) | (0.73) | (2.27) | (1.51) | (1.46) |
Free Cash Flow per Share |
1.66 | 3.74 | 2.34 | 2.12 | 2.09 | 0.92 | 2.76 | 2.28 | 2.35 | 2.53 |
Cash per Share |
1.13 | 0.62 | 0.83 | 1.04 | 0.58 | 1.40 | 0.92 | 0.75 | 0.55 | 1.95 |
Shareholders Equity per Share |
12.57 | 15.62 | 17.05 | 17.39 | 16.95 | 38.18 | 23.04 | 23.65 | 24.90 | 21.67 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
12.57 | 15.62 | 17.05 | 17.39 | 16.95 | 38.18 | 23.04 | 23.65 | 24.90 | 21.67 |
Free Cash Flow |
1,939.00 | 4,465.90 | 2,803.60 | 2,569.80 | 2,525.80 | 552.70 | 1,425.70 | 1,175.40 | 1,255.30 | 1,296.60 |
Working Capital |
2,694.90 | 3,741.30 | 5,198.70 | 3,889.20 | 1,018.50 | 2,304.60 | 1,188.20 | 1,779.90 | 828.00 | 2,481.80 |
Capital Expenditures |
(376.90) | 2,163.00 | (96.40) | (429.20) | (491.10) | (679.10) | (378.00) | (1,166.30) | (809.50) | (750.60) |
Net Current Asset Value |
(12,692.60) | (13,344.70) | (14,242.00) | (18,314.50) | (23,447.20) | (25,731.40) | (12,614.40) | (14,200.10) | (15,285.40) | (16,086.10) |
EV/EBIT |
0.00 | 2,981.42 | 40.21 | 19.70 | 0.00 | 0.00 | 32.95 | 30.45 | 26.93 | 51.43 |
Capex to Sales |
0.03 | (0.15) | 0.01 | 0.03 | 0.03 | 0.06 | 0.03 | 0.10 | 0.07 | 0.07 |
Price to Operating Income |
0.00 | 1,471.20 | 17.84 | 8.54 | 0.00 | 0.00 | 14.49 | 15.57 | 16.03 | 28.69 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.19 | 1.21 | 1.20 | 1.00 | 1.41 | 0.64 | 0.94 | 0.97 | 0.77 | 0.66 |
Cash ROIC |
5.97% | 12.63% | 7.08% | 6.18% | 5.70% | 1.06% | 5.47% | 4.45% | 4.25% | 4.47% |
Accounts Receivable Turnover |
4.57 | 4.26 | 4.11 | 4.03 | 3.93 | 3.02 | 3.87 | 3.52 | 3.44 | 3.69 |
Accounts Payable Turnover |
5.15 | 4.81 | 4.85 | 5.70 | 6.91 | 4.75 | 4.83 | 4.84 | 5.09 | 5.19 |
Inventory Turnover |
2.37 | 2.49 | 2.57 | 2.61 | 2.61 | 2.00 | 2.90 | 2.90 | 2.85 | 2.90 |
Average Days of Payables |
68.94 | 74.22 | 78.71 | 66.03 | 49.14 | 85.29 | 73.36 | 79.41 | 74.41 | 77.13 |
Days of Inventory on Hand |
157.19 | 154.32 | 140.90 | 131.54 | 117.93 | 245.08 | 128.22 | 126.71 | 130.26 | 140.53 |
Average Receivables |
3,126.30 | 3,460.85 | 3,757.45 | 4,040.45 | 4,555.10 | 3,951.30 | 2,969.90 | 3,246.70 | 3,461.65 | 3,000.00 |
Average Payables |
1,803.90 | 1,895.95 | 1,852.40 | 1,712.00 | 1,780.80 | 1,716.15 | 1,572.55 | 1,534.75 | 1,400.30 | 1,228.85 |
Average Inventory |
3,926.65 | 3,661.90 | 3,494.60 | 3,748.60 | 4,724.80 | 4,071.40 | 2,625.55 | 2,561.45 | 2,499.55 | 2,203.70 |
Average Assets |
39,347.00 | 44,593.20 | 48,853.85 | 52,432.50 | 58,197.90 | 46,404.25 | 31,995.20 | 34,270.60 | 35,266.25 | 28,496.95 |
Average Common Equity |
16,673.40 | 19,551.45 | 20,769.85 | 20,782.50 | 21,723.40 | 17,418.95 | 12,025.45 | 12,737.35 | 12,212.60 | 10,441.70 |
Columns are period end dates